New Delhi [India], October 8 (ANI): A health expert from the Standing National Committee on Saturday asserted that there are several "missing links" that need to be probed in the World Health Organisation's (WHO) claim of over 66 deaths due to cold and cough syrup produced by the Maiden Pharmaceuticals Ltd.

Gurugram (Haryana) [India], September 13 (ANI/BusinessWire India): Cervical cancer is the fifth most common cancer among women globally according to World Health Organization (WHO). India accounts for one-fifth (1/5th) of the global burden of the disease. Every year in India, approximately 1.23 lakh women are diagnosed with cervical cancer and around 67,000 die from the disease. It is the second most common cancer affecting women in India. India has a population of approximately 43 crores women aged 15 years and older who are at risk of developing cervical cancer.

New Delhi [India], September 11 (ANI): Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous booster, sources told ANI.

Hyderabad (Telangana) [India], July 22 (ANI): As India is cementing Hyderabad's position as the "Vaccine Capital of the World", Biological E has announced its expansion plans for vaccine manufacturing with an overall investment of more than Rs 1,800 crore.

Pune (Maharashtra) [India], June 29 (ANI): India's first indigenously developed mRNA vaccine against the COVID-19 gets the Emergency Use Authorization (EUA), to be sold under the brand name GEMCOVAC™-19 and will be rolled out soon, informed the officials on Wednesday.

New Delhi [India], May 4 (ANI): Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said.

New Delhi [India], May 2 (ANI): The Supreme Court on Monday while saying that bodily autonomy and integrity are constitutional rights and no individual can be forced to get vaccinated against COVID also affirmed the Central government's COVID-19 vaccination policy.

New Delhi [India], April 30 (ANI): The National Technical Advisory Group on Immunisation (NTAGI) recommended that the Russian COVID-19 vaccine Sputnik Light which contains the same ingredients as the first dose of Sputnik V can be taken as a precaution dose, said Sources.

New Delhi [India], April 27 (ANI): In his interaction with Chief Ministers of several states, Prime Minister Narendra Modi on Wednesday warned that the Covid-19 crisis has not yet been overcome, stressing the importance of prioritising administration of vaccines to every eligible child at the earliest and the need to ensure Covid-appropriate behaviour in public places.

New Delhi Apr 26 PTI Indias drug regulator has granted emergency use authorisation for Biological Es COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotechs Covaxin for children in the age group of six to 12 years official sources said on TuesdayThe approval by the Drugs Controller General of India DCGI comes following recommendations by the Subject Expert Committee SEC on COVID-19 of the Central Drugs Standard Control OrganisationCDSCOThe SEC had last week reviewed the application of both the companies seeking emergency use authorisation for Corbevax and Covaxin for use in children of five to 12 years andsix to 12 years age group respectivelyBiological Es Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years Covaxin has been granted Emergency Use Listing EUL by the DCGI for the age group of 12 to 18 years on December 24 2021India began inoculating children aged 12-14 on March 16 The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers getting inoculated in the first phase Vaccination of frontline workers started from February 2 last yearThe next phase of COVID-19 vaccination commenced on March 1 last year for people over 60 years of age and those aged 45 and above with specified co-morbid conditionsIndia launched vaccination for all people aged more than 45 years from April 1 last year The government then decided to expand its vaccination drive by allowing everyone above 18 years of age to be inoculated against the viral disease from May 1 last yearThe next phase of vaccination commenced on January 3 for adolescents in the age group of 15-18 yearsIndia began administering precaution doses of vaccines to healthcare and frontline workers and those aged 60 and above with comorbidities from January 10 Precaution doses of COVID-19 vaccines to all aged above 18 years were allowed at private vaccination centres from April 10 PTI PLB NSD NSD